Clinical trials on a new treatment expected to improve the survival rates for sufferers of lung and ovarian cancer will begin soon in South Australia. Recruiting patients for the trials will start in early 2020 thanks to a partnership between AusHealth and researchers at the Royal Adelaide Hospital. RAH Cancer Clinical Trials Unit chief Michael… Read More: Trials to begin on new cancer treatment »
FDA Approves Reblozyl (luspatercept-aamt) for the Treatment of Anemia in Adults With Beta Thalassemia Who Require Regular Red Blood Cell Transfusions Print this page SUMMIT, N.J. & CAMBRIDGE, Mass.–(BUSINESS WIRE)– Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced the U.S. Food and Drug Administration (FDA) has approved Reblozyl (luspatercept-aamt) for the… Read More: FDA Approves Reblozyl (luspatercept-aamt) for the Treatment of Anemia in… »
The number of children who received hospital treatment for allergies has increased by 65% across England in the past five years, figures have revealed. In 2013-14, 2,873 teenagers sought treatment whereas in 2017-18 it was 4,743, data from NHS Digital shows. Allergy UK said this could be because this was the age when sufferers started… Read More: Allergies: Teenagers needing hospital treatment up 65% in five years »
What Are Varicose Veins, and What Causes Them? Blood is meant to travel from your heart throughout your body via your veins. These veins have valves that open to let blood flow past and close off behind it. When these valves aren’t working correctly or become weak, blood is then backed up around the vein… Read More: Is There Treatment for Varicose Veins? »